Skip to main content

How Neuromodulation Devices Market Will Grow In Coming Future Despite COVID-19 Chaos?

  The neuromodulation devices market is predicted to grow significantly in the forecast period despite of the pandemic COVID-19 situation. The growth for the market is predicted due to rise in the prevalence of the chronic diseases across the globe. Mostly, people use to be dependent on various dugs and medication to cure themselves where the patient curing success ratio was very less as compared to neurological treatment. The hospitals are struggling as the disease is spreading more than the production of masks, sanitizers, ventilators and tests. The neuromodulation devices are predicted to treat the corona patients and the process is under trial. SARS-Cov2 is likely to be responsible for acute respiratory failure and are treated with the help of neuromodulation devices.

[ What will the sample contain?
The sample will give the stakeholder an outline of the report. It will give an overview/framework of the aspects of the market that have been covered in the content of the actual report. The report, unlike the sample, will bear numerical data and market insights associated with a price. ]

At the pandemic situation many firms are under process for getting a device to cure corona virus with the help of a type in neuromodulation device. Vagus nerve stimulation is a type of neuromodulation device which can be treated through nerves which connects bidirectional to various organs, which includes even lungs. So, vagus nerve stimulation are under trial and are mostly used to lessen pain that occurs because of corona virus and the patient is predicted to recover within 15 days.

As per a new report published by Research Dive, the global neuromodulation devices market is set to generate a revenue of $ 26,418.6 by 2026, at a CAGR of 19.7% during the forecast period from 2019 to 2026.

The segmentation of the market has been done on the basis of type, application, end user and region. The report provides in-depth insights on drivers, vital segments, opportunities, restraints, and key players of the market. As per our analysts, increasing prevalence’s of chronic diseases such as depression, epilepsy, spinal problem and other diseases among the population is predicted to boost the neuromodulation devices market. Moreover, the cost involved in treating neurological diseases is very high, which is predicted to hinder the neuromodulation devices market in the forecast period.

Cheddar type segment is predicted to be most lucrative

Depending on type, the neuromodulation devices market is segmented into internal neuromodulator and external neuromodulator. Internal Neuromodulation segment accounted for $3,647.5 million in 2018 and is predicted to grow with a CAGR of 19.4% in the forecast period. Internal neuromodulation is the most cost effective and is the most effective way of treating chronic pain, tremor, and several diseases, which is predicted to boost the internal neuromodulation segment in the forecast period.

Supermarket distribution channel is predicted grow immensely in the forecast period

Depending on application, the neuromodulation devices market is segmented into spinal cord stimulation, deep brain stimulation, sacral nerve stimulation, vagus nerve stimulation, gastric electrical stimulation, transcutaneous electrical nerve stimulation, repetitive transcranial magnetic stimulation, respiratory electrical stimulation and others. Spinal cord stimulation segment was accounted for $1,193.7 million in 2018 and is predicted to grow with a CAGR of 18.9% in the forecast period. The neuromodulation devices are mostly used for the treatment of the spinal cord treatment across the globe is predicted to boost the spinal cord stimulation segment in the forecast period.

Hospital end use segment is predicted to have the highest share in the forecast period

Depending on end use, the neuromodulation devices market is segmented into clinical, hospital and home health care. Hospital segment accounted for $3,382.2 million in 2018 and is predicted to grow with a CAGR of 19.3% in the forecast period.

Geographical Analysis and Major Market Players

On the basis of region, the global disaster recovery as a service market is segmented into North America, Europe, Asia Pacific, and LAMEA. Asia-Pacific market is predicted to grow with a CAGR of 19.7% in the forecast period by generating a revenue of $26,418.6 million by 2026.Increasing cases of neurological disorders, increasing investment in private & public hospitals & clinics with government initiatives is predicted to boost the overall market in the forecast period.

The major key players in the neuromodulation devices market are Boston Scientific Corporation, Neuronetics, Inc., Beijing PINS Medical Co., Ltd., Neuropace Inc. Bioness Inc., Nevro Corporation, LivaNova Plc, Abbott Laboratories and Medtronic Plc among others.

Contact Us:

Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
+1 (917) 444-1262 (US)
Toll Free : +1 -888-961-4454
Email: support@researchdive.com
LinkedIn: https://www.linkedin.com/company/research-dive
Twitter: https://twitter.com/ResearchDive
Facebook: https://www.facebook.com/Research-Dive
Blog: https://www.researchdive.com/blog
Follow us on: https://covid-19-market-insights.blogspot.com

Comments

Post a Comment

Popular posts from this blog

COVID-19 Impact: Which Are the Key Players Evolving In the Growth of Assisted Reproductive Technology Market?

   The worldwide spread of COVID-19 has positively impacted the   global assisted reproductive technology market . This is mainly due to supportive government policies and the strategic steps taken by major market players in the pandemic crisis. For instance, in June 2020, SART launched its fertility expert’s podcast series. Furthermore, the global market is expected to observe substantial growth even after the pandemic owing to the growing adoption of R&D and growing awareness amongst people regarding assisted reproductive technology. The global assisted reproductive technology market is likely to experience an increase in the growth rate during the COVID-19 pandemic. As per a new report added by Research Dive, the global assisted reproductive technology market is anticipated to reach up to $56.3 billion during the forecast period from 2019 to 2026. Comprehensive analysis on drivers, challenges, growth opportunities, major segments, and key strategies executed by maj...
Post a Comment
Read more

Why Dynamics of Organ Care System Market for Liver Is Changing Drastically? What If History Is Any Guide?

   The COVID-19 outbreak has helped the global organ care system market to grow at a positive rate. The manufactures of the industry are investing more in R&D activities to grow exponentially during the forecast period. The COVID-19 pandemic has positively impacted the global Organ care system (OCS) for liver market and a slight increase in the growth rate is observed from the previous predictions. As per new Research Dive published report, the global OCS for liver market is anticipated to grow at a CAGR of 9.3% by 2026, generating a revenue of $42.7 million in the period of forecast from 2019 to 2026. To better understand the pandemic effect on the global market, the report includes comprehensive analysis on growth opportunities, restraints, drivers, vital segments, and strategies adopted by major market players. For More Detail Insights, Download FREE Sample at:   https://www.researchdive.com/download-sample/253 Highlights of the Report As per our analysts, the risi...
Post a Comment
Read more

COVID-19 Impact: What Challenges Medical Tourism Market May See In Next 5 Years?

   The COVID-19 crisis has affected the global medical tourism market in a negative way. The governments are taking initiatives to help patients seek healthcare treatment and the market is likely to recover by Q1/Q2 of 2022. The COVID-19 pandemic has hugely impacted the global medical tourism market and a slight downfall is witnessed in the growth rate as compared to the former predictions. As per new Research Dive published report, the global medical tourism market is anticipated to rise at a CAGR of 11.7% by 2026, generating a revenue of $142.2 billion in the period of forecast from 2019 to 2026. While there is a decrease in the growth rate due to the COVID-19 outbreak, the market is likely to recover by Q1/Q2 of 2022. For More Detail Insights, Download FREE Sample at :   https://www.researchdive.com/download-sample/248 Highlights of the Report As per our analysts, the increasing interests amongst people coupled with technological advancements in healthcare treatment is...
Post a Comment
Read more